Table 2.
Adverse outcomes of high and low performance-based functional assessments groups and dichotomous summary score in the Safe Kidney Care cohort
| Outcome | Total (N) | n (%) | |||||||
| High SPPB | Low SPPB | High IADL | Low IADL | High M3SE | Low M3SE | High Summary Score | Low Summary Score | ||
| Participants | 350 | 197 (56) | 153 (44) | 246 (70) | 104 (30) | 177 (51) | 173 (49) | 213 (61) | 137 (39) |
| ESKD | 41 | 20 (10) | 21 (14) | 32 (13) | 9 (9) | 21 (12) | 20 (12) | 24 (11) | 17 (12) |
| Death | 56 | 20 (10) | 36 (24)a | 32 (13) | 24 (23)b | 20 (11) | 36 (21)b | 23 (11) | 33 (24)a |
| ESKD or 50% decline GFR | 52 | 21 (11) | 31 (20)b | 42 (17) | 10 (10) | 26 (15) | 26 (15) | 30 (14) | 22 (16) |
| ESKD, 50% decline GFR, or death | 106 | 41 (21) | 65 (43)c | 72 (29) | 34 (33) | 45 (25) | 61 (35)b | 52 (24) | 54 (39)a |
P values compared two groups listed side by side. SPPB, Short Physical Performance Battery; IADL, Lawton Instrumental Activities of Daily Living; M3SE, Modified Mini-Mental Status Exam.
a
P≤0.001.
b
P≤0.05.
c
P≤0.0001.